Marshall Wace
NNNN

Marshall Wace’s Anbio Biotechnology NNNN Stock Holding History

Marshall Wace’s Portfolio NNNN Stock Details NNNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158K Buy
+11,502
New +$288K ﹤0.01% 2867
2025
Q4 		– Sell
-10,443
Closed -$389K – 3619
2025
Q3 		$389K Buy
+10,443
New +$469K ﹤0.01% 2326
2025
Q2 		– Sell
-43,629
Closed -$325K – 3303
2025
Q1 		$325K Buy
+43,629
New +$298K ﹤0.01% 2239

Other funds holding NNNN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFS
Bare Financial Services Gap, Pennsylvania $436M AUM 20.22% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.81B AUM 32.31% 1-Year Est. Return

Marshall Wace's NNNN Position: Q2 2026 in Review

Marshall Wace opened a new position in Anbio Biotechnology (NNNN) in Q2 2026: 11,502 shares worth $158K. The stake represents ﹤0.01% of the portfolio and ranks #2867 among its holdings. This is a return to the name: Marshall Wace previously reported a position in NNNN as recently as Q3 2025.

Marshall Wace first reported a position in NNNN in Q1 2025 and has held it in 3 quarters since. The position peaked at $389K in Q3 2025. 12 funds tracked by Wall St. Rank hold NNNN as of Q2 2026.

  • Marshall Wace held 11,502 shares of Anbio Biotechnology worth $158K as of Q2 2026.
  • Anbio Biotechnology was a new Marshall Wace position in Q2 2026.
  • Anbio Biotechnology made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2867 holding.
  • Marshall Wace first reported a position in Anbio Biotechnology in Q1 2025 and has held it in 3 quarters since.
  • Marshall Wace's Anbio Biotechnology position peaked at $389K in Q3 2025.
  • 12 funds tracked by Wall St. Rank held Anbio Biotechnology as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.